MedCity News
NOVEMBER 23, 2023
With proposed requirements ranging from accessible self-service kiosks to accessible medical equipment, the impact of this new rule will be wide-ranging with financial, operational, and practical consequences.
European Pharmaceutical Review
NOVEMBER 23, 2023
Boehringer Ingelheim is acquiring Swiss biotech T3 Pharmaceuticals AG (T3 Pharma), for up to £406 million (450 million CHF), boosting its immuno-oncology portfolio. The pharmaceutical company will utilise T3 Pharmaceutical’s proprietary bacterial cancer therapy platform that consisting that delivers immune-modulating bioactive proteins to cancer cells and tumour micro-environments.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedCity News
NOVEMBER 23, 2023
Proposals targeting misaligned financial incentives, price transparency, and pharmacy access are important and necessary reforms. But the consequences of failing to address pharmacy benefit managers’ use of market power to block competition and extract monopoly profits from payers and consumers will not be limited to drug costs – it will change all of healthcare for generations.
European Pharmaceutical Review
NOVEMBER 23, 2023
Following the UK government’s recent announcement of a £520 million funding boost for UK manufacturing, a new Oligonucleotide Manufacturing Innovation Centre of Excellence in Scotland will develop innovative and sustainable techniques for these medicines. According to the Centre for Process Innovation (CPI), oligonucleotides therapeutics use short, chemically synthesised fragments of DNA or RNA to modulate protein expression and ultimately treat the underlying cause of disease.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
pharmaphorum
NOVEMBER 23, 2023
US biotech Moderna has completed the installation of its clinical laboratories at its new R&D facility in the UK dedicated to the discovery of new mRNA vaccines and therapeutics, part of a 10-year partnership with the government agreed last year that has been estimated to be worth around £1 billion.
European Pharmaceutical Review
NOVEMBER 23, 2023
Last month at CPHI Barcelona 2023 , EPR interviewed Mohamed Noor, Digitalization Manager at the National Institute for Bioprocessing Research and Training ( NIBRT ). During the conversation, Noor shed light on how digitalisation is impacting the biopharmaceutical industry. Additionally, he explored the trends, challenges and opportunities for process analytical technology (PAT).
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
pharmaphorum
NOVEMBER 23, 2023
AstraZeneca joins KRAS push in cancer with Chinese deal Phil.
PharmaTimes
NOVEMBER 23, 2023
Both companies will use their platforms to accelerate drug discovery and development - News - PharmaTimes
pharmaphorum
NOVEMBER 23, 2023
Lord James O’Shaughnessy has welcomed the UK government’s official response to his review of commercial clinical trials, saying there have been a number of positive developments since it was published in the spring.
PharmaTimes
NOVEMBER 23, 2023
ADP101 is an oral immunotherapy to treat multi-food and single-food allergies - News - PharmaTimes
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
NOVEMBER 23, 2023
Novo Nordisk will invest €2.1bn in French manufacturing site Phil.
Impetus Digital
NOVEMBER 23, 2023
A version of this article was previously published in the Journal of mHealth. With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start popping up. Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. Others might talk about the return of in-person meetings after the COVID-19 pandemic.
Clarivate
NOVEMBER 23, 2023
As AI becomes part of the fabric of our personal and professional lives, its use continues to reveal both its potential and limitations. The speed and accuracy of drug discovery and development are being transformed by AI and machine learning (ML) applications. AI and life science companies alike need to conduct due diligence to ensure optimal results and avoid the pitfalls of poor data sources and an over-reliance on technology’s capabilities.
Pharmaceutical Technology
NOVEMBER 23, 2023
EirGenix and Sandoz's biosimilar has been approved for all the indications as the reference biologic, Roche’s Herceptin.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
pharmaphorum
NOVEMBER 23, 2023
InDex craters on phase 3 ulcerative colitis failure Phil.
Pharmaceutical Technology
NOVEMBER 23, 2023
SK bioscience has signed an agreement with Hilleman Laboratories Singapore for the co-development of a vaccine against the Zaire Ebola virus.
PharmaTech
NOVEMBER 23, 2023
Chris Spivey, editorial director for Pharmaceutical Technology and Biopharm International, spoke with Concetto Andrea Rizza, Marketing and Communications manager, ICE Pharma, on sustainability and ICE’s green approach at CPhI Barcelona 2023.
Pharmaceutical Technology
NOVEMBER 23, 2023
The fast track designation for the paediatric multi-food allergy therapy ADP101 was based on the Phase I/II data.
PharmaTech
NOVEMBER 23, 2023
Hovione has acquired start-up company, ExtremoChem, expanding its technology platforms.
Pharmaceutical Technology
NOVEMBER 23, 2023
China’s NMPA has accepted NDA for AnHeart Therapeutics taletrectinib to treat locally advanced or metastatic ROS1-positive NSCLC.
PharmaTech
NOVEMBER 23, 2023
UK industry body, ABPI, has responded positively to the recent Autumn Statement.
Pharmaceutical Technology
NOVEMBER 23, 2023
When expectant mothers are diagnosed with gestational diabetes mellitus (GDM) they often feel anxious and need extra support.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmacy Times
NOVEMBER 23, 2023
Pediatric individuals that are higher risk for APS must be followed to better understand affects
Pharmaceutical Technology
NOVEMBER 23, 2023
Simcere will have the rights to develop and commercialise rademikibart in mainland China, Macau, Taiwan, and Hong Kong.
Pharmaceutical Technology
NOVEMBER 23, 2023
Syncona has signed a definitive agreement to acquire clinical-stage biotechnology company Freeline Therapeutics
Pharmaceutical Technology
NOVEMBER 23, 2023
Biotech company Vivodyne has raised $38m in total seed financing for the development of lab-grown human organs.
Expert insights. Personalized for you.
125 
Let's personalize your content